H. Daniel Perez
Founder, President, CEO and Chairman of the Board at Naia Pharmaceuticals
Greenbrae, US
About
H. Daniel Perez, MD, a Venture Partner with Bay City Capital since 2007, was previously President and CEO of Berlex (the US arm of Schering AG) where he led the company's R&D efforts in the US and overseas, initiated multiple human clinical trials, and oversaw the execution of numerous collaborations, licensing deals, spin-outs and acquisitions, until leaving the company in 2006 upon its acquisition by Bayer. Dr. Perez is on the Board of Directors of Celtaxys and Presidio Pharmaceuticals, and serves on the Scientific Advisory Boards of Cardium and Vertex Pharmaceuticals. He is also a member of the Investment Board of GSK, China, and the President's Council for the Gladstone Institutes at the University of California, San Francisco (UCSF). He was a member of the Board of Directors of BayBio and Cleveland Biolabs. Dr. Perez received his medical degree in Buenos Aires, Argentina and completed his medical training at Beth Israel-Mount Sinai in New York City, as well as a fellowship in r
Position in the VCSift Database
- • 1 investors hold the Founder, President, CEO and Chairman of the Board role in VCSift. H. Daniel Perez is one of them.
- • 7 investors are based in Greenbrae, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Greenbrae, US
Contact Information
Find more investors like H. Daniel
Search Investors